- Home
- AXG vs OLMA Comparison
AXG vs OLMA Comparison
Compare AXG & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXG | OLMA |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.3M | 725.5M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AXG | OLMA |
|---|---|---|
| Price | $3.17 | $27.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | 823.5K | ★ 7.8M |
| Earning Date | 06-30-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,316,000.00 | N/A |
| Revenue This Year | $28.53 | N/A |
| Revenue Next Year | $54.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.16 | $2.86 |
| 52 Week High | $5.09 | $29.51 |
Technical Indicators
Market Signals| Indicator | AXG | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 81.22 |
| Support Level | N/A | $26.20 |
| Resistance Level | N/A | $28.45 |
| Average True Range (ATR) | 0.00 | 2.87 |
| MACD | 0.00 | 0.57 |
| Stochastic Oscillator | 0.00 | 89.42 |
Price Performance
Historical ComparisonAbout AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.